Complete report $1,850. DataPack (test volumes, sales forecasts, supplier shares) $1,200. The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.
This new study from Venture Planning Group contains 407 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testig for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years.
Report Highlights
- Market shares of leading suppliers
- Business and technological trends in major markets
- Five-year test volume and sales forecasts
- Market shares of leading competitors
- Feature comparison of major analyzers
- Strategic profiles of leading market players and start-up firms developing innovative products
- Specific product and business opportunities for instrument and consumable suppliers.
Rationale
Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by these markets, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.
Germany Market Overview
- Laboratories performing DNA sequencing and molecular diagnostic testing by country and market segment.
- Five-year test volume and sales projections.
Market Segmentation Analysis
- Five-year test volume and sales projections:
- Infectious Diseases - Forensic Testing
- Cancer - Paternity Testing/HLA Typing
- Genetic Diseases - Others
- A comprehensive analysis of the sequencing market by laboratory segment.
- Detailed market segmentation analysis, including review of the market dynamics, trends,
structure, size, growth and major suppliers.
Product/Technology Review
- Comparison of the major molecular diagnostic analyzers.
- Extensive review of molecular diagnostic technologies, test formats, detection methodologies,
trends in testing automation and over target/signal amplification methods.
- Worldwide listings of companies, universities and research centers developing new molecular
diagnostic technologies and products.
Competitive Assessments
- Extensive strategic assessments of major suppliers and emerging market entrants,
including their sales, product portfolios, marketing tactics, collaborative arrangements and
new technologies/products in R&D.
- Abbott
- Affymetrix
- Agilent Technologies
- Applied Gene Technologies
- Arca/Nuvelo
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- BioMerieux
- Bio-Rad
- Biotest
- Caliper
- Cepheid
- Decode
- Diadexus
- Eiken
- Enzo
- Exact Sciences
- Fujirebio/Innogenetics
- Grifols
- Hologic/Gen-Probe
- Illumina
- Kreatech
- Li-Cor Biosciences
- Life Technologies/Thermo Fisher
- Monogram Biosciences
- Myriad Genetics
- Nanogen/Elitech
- Orchid CellMark
- Ortho-Clinical Diagnostics
- Proteome Sciences
- Qiagen
- Roche
- Scienion
- Sequenom
- Shimadzu
- Siemens
- Sierra Molecular
- Takara Bio
- Tecan Group
- Comprehensive listings of companies developing and marketing molecular
diagnostic products, by test and application.
Opportunities and Strategic Recommendations
- Specific new product development opportunities with potentially significant market appeal
during the next five years.
- Design criteria for new products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
- Business planning issues and concerns.
Contains 407 pages
I. Outlook
Introduction
Industry Consolidation and Diversification: A Biomodal Trend
Market Globalization
Pricing Pressures
Productivity
II. Major Geographic Regions
North America
Europe
Japan
Latin AmericaIntroduction
Global Market Trends and Emerging Technologies
A. DNA Sequencing
B. DNA and RNA Probe Technology
C. Detection Technologies
D. Instrumentation: Review of Automated and Semi-Automated Analyzers
E. Biochips: Genosensors, Microarrays, Labs-on-the-Chip
F. Pharmacogenomics
G. Cancer Molecular Diagnostics Testing
1. Overview
2. Major Cancer Types
3. Oncogenes
H. Genetic Diseases Molecular Diagnostic Testing
1. Overview
2. Nucleic Acid Amplification
3. Chromosome Imaging
4. Genomics Technologies
5. Proteomics Technologies
6. Current Pharmacogenomic Testing
7. Major Diseases
I. Forensic Molecular Diagnostics Testing
1. Overview
2. Multilocus and Single Locus Probes
3. The FBI
Table of Contents (continued)
4. DNA Profile Data Banks
5. Judicial Implementation
6. Major Crime Categories
7. Factors Contributing to the DNA Probe
Major Expansion
J. Paternity Testing/HLA Typing Molecular Diagnostic Testing
K. Other Molecular Diagnostic Testing Applications
L. Competing/Complementing Technologies
Germany
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
- Volume Forecasts by Market Segment
- Sales Forecasts by Market Segment
- Major Supplier Sales and Market Shares
Major Product Development Opportunities
A. Opportunities for New Instrumentation
B. Opportunities for New Reagent Kits and Test Systems/Panels
C. Opportunities for New IT, Computers, Software and Automation
D. Opportunities for New Auxiliary Products
Design Criteria For Decentralized Testing Products
Alternative Market Penetration Strategies
Potential Market Entry Barriers And Risks
Competitive Profiles
- Abbott
- Affymetrix
- Agilent Technologies
- Applied Gene Technologies
Table of Contents (continued)
- Arca/Nuvelo
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- BioMerieux
- Bio-Rad
- Biotest
- Caliper
- Cepheid
- Decode
- Diadexus
- Eiken
- Enzo
- Exact Sciences
- Fujirebio/Innogenetics
- Grifols
- Hologic/Gen-Probe
- Illumina
- Kreatech
- Li-Cor Biosciences
- Life Technologies/Thermo Fisher
- Monogram Biosciences
- Myriad Genetics
- Nanogen/Elitech
- Orchid CellMark
- Ortho-Clinical Diagnostics
- Proteome Sciences
- Qiagen
- Roche
- Scienion
- Sequenom
- Shimadzu
- Siemens
- Sierra Molecular
- Takara Bio
- Tecan Group
Appendixes
List of Tables
Oncogenes Potential Applications in Cancer Diagnosis
Major Companies Developing or Marketing Cancer
Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular Diagnostic Tests
For Genetic Diseases
Germany, Laboratories Performing
DNA Sequencing by Market Segment
Germany, Molecular Diagnostics Market
Potential Laboratory Universe by Market Segment
Germany, Molecular Diagnostic Test Volume Forecast
By Major Application
Germany, Molecular Diagnostic Market Forecast
By Major Application
Germany, Molecular Diagnostics
Market by Major Supplier
III. Major Modalities
X-Ray
Ultrasound
MRI
CT
Nuclear Medicine
PET
PACS
IV. Market Size and Growth
V. Strategic Directions
Business, new product development, and marketing strategies
Anticipated acquisitions, joint ventures, and divestitures
VI. Marketing Tactics
The U.S. and international sales force size in major geographic regions
Selling options, including rental plans, leasing and others
Promotional tactics, e.g., pricing, discounts, advertising, trade shows,
seminars, product literature, newsletters, etc
System service and support
VII. Technological Know-How
Internally developed and acquired diagnostic imaging and related
technologies, Including X-ray, ultrasound, MRI, CT, nuclear medicine, PET,
PACS, and others.
List of Tables
Table 1: Worldwide Diagnostic Imaging Market
Estimated Sales by Geographic Region and Country
Table 2: Worldwide Diagnostic Imaging Market
Estimated Sales Growth by Geographic Region and Country
Table 3: Worldwide Diagnostic Imaging Market
Estimated Sales by Modality and Business
Table 4: Worldwide Diagnostic Imaging Market
Estimated Sales by Modality/Business
And Geographic Region
Table 5: Worldwide Diagnostic Imaging Market
Estimated Sales Growth by Modality/Busine
Contact us at the Consulting WP office nearest to you or submit a business inquiry online.
Subscribe to Our Newsletter
Published On : November 2019
$ 3600
Published On : November 2019
$ 3600
Published On : November 2019
$ 3600
$ 3950
Published On : April 2019
$ 3000